Reduction of Antibiotic Resistance Genes in Intestinal Microbiota of Patients With Recurrent Clostridium difficile Infection After Fecal Microbiota Transplantation
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
To the Editor—We read with great interest the recent report by Millan et al studying antibiotic resistance (ABR) genes in patients' microbiota after successful fecal microbiota transplantation (FMT) treatment of recurrent Clostridium difficile infection (rCDI) [1]. The authors reported reduction of both number and diversity of ABR genes in 20 rCDI patients post-FMT compared with pre-FMT fecal samples [1]. Analysis was conducted by using metagenomic sequencing and DNA microarray targeting 354 ABR genes [1]. In our present study, we determined the presence of ABR genes in fecal samples from 3 donors and 8 patients successfully treated with FMT for rCDI [2]. We used quantitative polymerase chain reaction (qPCR) array for 85 ABR genes (Microbial DNA qPCR Array for Antibiotic Resistance genes, Qiagen) and found 33 genes across all samples. The detected genes belonged to 8 different resistance classes: β-lactam ases and beta-lactam resistance (15 genes), fluoroquinolone (6), macrolide, lincosamide, and streptogramin (5), aminoglycoside (2), tetracycline efflux pumps (2), vancomycin (2) and multidrug efflux pumps (1 gene). Similarly to Millan et al, we observed reduction in both the number and diversity of ABR genes in the patients’ samples taken 1 or 2 months after FMT compared with samples prior to FMT (Figure 1). This was apparent regardless of fewer ABR genes being included in our array than in Millan et al's [1]. Thus, our results confirm the recent findings by Millan et al in an independent group of patients. The numbers of antibiotic resistance (ABR) genes (A) and the number of unique and shared genes (B) in fecal samples of donors (n = 3) and patients (n = 8) before and after fecal microbiota transplantation (pre-FMT and post-FMT, respectively) for recurrent Clostridium difficile infection. Box plot shows the medians and quartiles 1 and 3 in boxes and minimum and maximum numbers of ABR genes in the studied groups in whiskers. The Student t test was used to assess the statistical significance between patients pre- and post-FMT (data normally distributed). FMT is an effective treatment for rCDI, with a >90% recovery rate [2–4]. FMT restores the normal composition and diversity of microbiota [1, 4, 5] to resemble that of the healthy donor and consequently provides colonization resistance against C. difficile. Currently, FMT is considered for other indications due to its efficacy in modifying gut microbiota. We agree with the suggestion by Millan et al of using FMT as a treatment option to eradicate multidrug-resistant bacteria from patients [1]. However, it should be acknowledged that although FMT reduces ABR genes in patients, it can also introduce new resistances into the patients’ microbiota. We observed a possible transfer of resistance via FMT; the vanB resistance gene was found in all 3 donors and in all the patients post-FMT, but not pre-FMT. Transfer of nonpathogenic ABR genes, including nonenterococcal transfer of vanB, may be a common scenario in FMT considering the repertoire of resistance genes in fecal donors and healthy adults. Concerning vanB, the gene is commonly found in different intestinal species such as Clostridium, Ruminococcus, and Eggerthella species and even in food-grade lactobacilli [6, 7], and up to 63% of community adults have been found to be nonenterococcal vanB carriers [8, 9]. Nevertheless, our results call for enhanced donor screening programs with consideration of ABR genes too. The importance of even more thorough donor screening is further emphasized by the recent observation that donors’ strains transferred in FMT persist for months [10]. Thus, alongside the increased use of FMT, the donor screening procedures should be constantly improved. Financial support. This work was supported by the Academy of Finland (grant numbers 2584391 and 283088). Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mattila, E., Uusitalo–Seppälä, R., Wuorela, M., Lehtola, L., Nurmi, H., Ristikankare, M., Moilanen, V., Salminen, K., Seppälä, M., Mattila, P. S., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.11.037 · Cited by 371
Self-citation
Cited by
Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence
Christaki, E., Marcou, M., & Tofarides, A. (2020) · Journal of Molecular Evolution · doi:10.1007/s00239-019-09914-3 · Cited by 780
Good microbes, bad genes? The dissemination of antimicrobial resistance in the human microbiome
Crits-Christoph, A., Hallowell, H. A., Koutouvalis, K., & Suez, J. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2055944 · Cited by 156
Vendrik, K. E. W., Terveer, E. M., Kuijper, E. J., Nooij, S., Boeije-Koppenol, E., Sanders, I. M. J. G., van Lingen, E., Verspaget, H. W., Berssenbrugge, E. K. L., Keller, J. J., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30473-4 · Cited by 49
Metadata
- Authors
- Jouhten, H., Mattila, E., Arkkila, P., & Satokari, R.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-06-17
- Volume
- 63
- Issue
- 5
- Pages
- 710-711
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2467162221
- Cited by
- 47
- References
- 1
- FWCI
- 5.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduction of Antibiotic Resistance Genes in Intestinal Microbiota of Patients With Recurrent Clostridium difficile Infection After Fecal Microbiota Transplantation. https://app.cochat.ai/papers/10.1093/cid/ciw390
- The paper
- Jouhten, H., Mattila, E., Arkkila, P., & Satokari, R. (2016). Reduction of Antibiotic Resistance Genes in Intestinal Microbiota of Patients With Recurrent Clostridium difficile Infection After Fecal Microbiota Transplantation. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciw390
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.